EUVIMEDEUVIMED entdecken
Video/AudioOpen Access

Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis

Debolina Banerjee, Sharif A Sabe, Hang Xing, Cynthia Xu, Mohamed Sabra, Dwight D Harris, Mark Broadwin, M Ruhul Abid, Anny Usheva, Jun Feng, Frank W Sellke

The Journal of Thoracic and Cardiovascular Surgery · 2023-12 · 166 (6) · e535-e550

DOI: 10.1016/j.jtcvs.2023.08.017 ↗

Kurz gefasst

Video/Audio in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2023-12. Verfasst von Debolina Banerjee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown Univ…. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Myocardial Ischemia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Sodium-glucose cotransporter-2 inhibitor, canagliflozin, improves myocardial perfusion to ischemic territory without accompanying changes in vascular density. We aimed to (1) characterize effects on angiogenic pathways, (2) use multiomics to identify gene expression and metabolite profiles relevant to regulation of myocardial blood flow, and (3) investigate drug effect on coronary microvascular reactivity. METHODS: A nondiabetic swine model of chronic myocardial ischemia and nondiabetic rat model were used to study functional and molecular effects of canagliflozin on myocardium and in vitro microvascular reactivity. RESULTS: Canagliflozin resulted in increased coronary microvascular vasodilation and decreased vasoconstriction (P .3). Expression of the angiogenic modulator, endostatin, increased (P = .008), along with its precursor, collagen 18 (P < .001), and factors that increase its production, including cathepsin L (P = .004). Endostatin and collagen 18 levels trended toward an inverse correlation with blood flow to ischemic territory at rest. Proangiogenic fibroblast growth factor receptor was increased (P = .03) and matrix metalloproteinase-9 was decreased (P < .001) with canagliflozin treatment. Proangiogenic vascular endothelial growth factor A (P = .13), Tie-2 (P = .10), and Ras (P = .18) were not significantly altered. Gene expression related to the cardiac renin-angiotensin system was significantly decreased. CONCLUSIONS: In chronic myocardial ischemia, canagliflozin increased absolute blood flow to the myocardium without robustly increasing vascular density or proangiogenic signaling. Canagliflozin resulted in altered coronary microvascular reactivity to favor vasodilation, likely through direct effect on vascular smooth muscle. Downregulation of cardiac renin-angiotensin system demonstrated local regulation of perfusion. VIDEO ABSTRACT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sodium-Glucose Transporter 2 InhibitorsMyocardial IschemiaSwineAnimalsRatsVasodilationCanagliflozinVascular Endothelial Growth Factor AEndostatinsMyocardium

Stichwörter der Autor:innen

angiogenesischronic myocardial ischemiamicrovascular reactivitymyocardial perfusion

Substanzen

CanagliflozinVascular Endothelial Growth Factor ASodium-Glucose Transporter 2 InhibitorsEndostatins

Autor:innen und Institutionen

  • Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI.
  • Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI. Electronic address: fsellke@lifespan.org.

Förderung

  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Banerjee, D., Sabe, S. A., Xing, H., Xu, C., Sabra, M., Harris, D. D., Broadwin, M., Abid, M. R., Usheva, A., Feng, J., & Sellke, F. W. (2023). Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis. The Journal of Thoracic and Cardiovascular Surgery, 166(6), e535-e550. https://doi.org/10.1016/j.jtcvs.2023.08.017

Vancouver

Banerjee D, Sabe SA, Xing H, Xu C, Sabra M, Harris DD, et al. Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis. The Journal of Thoracic and Cardiovascular Surgery. 2023;166(6):e535-e550. doi:10.1016/j.jtcvs.2023.08.017

BibTeX
@article{Banerjee2023,
  author = {Banerjee, Debolina and Sabe, Sharif A and Xing, Hang and Xu, Cynthia and Sabra, Mohamed and Harris, Dwight D and Broadwin, Mark and Abid, M Ruhul and Usheva, Anny and Feng, Jun and Sellke, Frank W},
  title = {Canagliflozin improves coronary microvascular vasodilation and increases absolute blood flow to the myocardium independent of angiogenesis},
  journal = {The Journal of Thoracic and Cardiovascular Surgery},
  year = {2023},
  volume = {166},
  number = {6},
  pages = {e535--e550},
  doi = {10.1016/j.jtcvs.2023.08.017}
}
Kostenlos starten →